KS1 accounts for up to 75% of Kabuki syndrome cases [3], and originates from heterozygous, typically de novo, pathogenic variants in KMT2D [4], which encodes a histone lysine methyltransferase that mono-, di-, and tri-methylates H3K4 [5,6]. The gene discussed is KMT2D; the disease is Kabuki syndrome.